Surgery Partners (SGRY) Competitors $21.73 -1.10 (-4.82%) As of 10:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGRY vs. HIMS, OPCH, GH, RDNT, SHC, BTSG, CON, PRVA, LFST, and WGSShould you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), LifeStance Health Group (LFST), and GeneDx (WGS). These companies are all part of the "healthcare" industry. Surgery Partners vs. Hims & Hers Health Option Care Health Guardant Health RadNet Sotera Health BrightSpring Health Services Concentra Group Holdings Parent Privia Health Group LifeStance Health Group GeneDx Hims & Hers Health (NYSE:HIMS) and Surgery Partners (NASDAQ:SGRY) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk. Does the MarketBeat Community believe in HIMS or SGRY? Surgery Partners received 270 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 57.75% of users gave Surgery Partners an outperform vote while only 37.07% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes4337.07% Underperform Votes7362.93% Surgery PartnersOutperform Votes31357.75% Underperform Votes22942.25% Does the media prefer HIMS or SGRY? In the previous week, Hims & Hers Health had 29 more articles in the media than Surgery Partners. MarketBeat recorded 32 mentions for Hims & Hers Health and 3 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.29 beat Hims & Hers Health's score of 0.85 indicating that Surgery Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 21 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Surgery Partners 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend HIMS or SGRY? Hims & Hers Health presently has a consensus price target of $37.31, indicating a potential upside of 33.31%. Surgery Partners has a consensus price target of $36.63, indicating a potential upside of 60.42%. Given Surgery Partners' stronger consensus rating and higher possible upside, analysts clearly believe Surgery Partners is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.27Surgery Partners 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78 Is HIMS or SGRY more profitable? Hims & Hers Health has a net margin of 8.19% compared to Surgery Partners' net margin of -2.03%. Hims & Hers Health's return on equity of 10.97% beat Surgery Partners' return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Surgery Partners -2.03%2.85%1.22% Which has stronger earnings & valuation, HIMS or SGRY? Surgery Partners has higher revenue and earnings than Hims & Hers Health. Surgery Partners is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B4.21-$23.55M$0.5451.82Surgery Partners$3.11B0.94-$11.90M-$1.33-17.17 Do insiders and institutionals have more ownership in HIMS or SGRY? 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 2.3% of Surgery Partners shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, HIMS or SGRY? Hims & Hers Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Comparatively, Surgery Partners has a beta of 2.4, suggesting that its share price is 140% more volatile than the S&P 500. SummaryHims & Hers Health and Surgery Partners tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Surgery Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGRY vs. The Competition Export to ExcelMetricSurgery PartnersGeneral medical & surgical hospitals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.91B$12.88B$5.54B$7.50BDividend YieldN/A0.64%4.86%4.04%P/E Ratio-47.565.6023.2418.07Price / Sales0.940.58361.2586.83Price / Cash14.306.8638.1634.64Price / Book0.9532.436.493.99Net Income-$11.90M$1.20B$3.21B$247.18M7 Day Performance-4.68%-2.41%-4.91%-4.25%1 Month Performance-4.08%-1.81%-0.08%-6.87%1 Year Performance-15.60%6.64%6.40%-3.73% Surgery Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGRYSurgery Partners2.6257 of 5 stars$21.73-4.8%$36.63+68.5%-17.0%$2.78B$3.11B-45.3813,500Positive NewsGap DownHIMSHims & Hers Health3.7987 of 5 stars$29.73+2.0%$37.31+25.5%+80.4%$6.60B$1.48B67.56650Gap DownOPCHOption Care Health3.8301 of 5 stars$34.95+0.6%$33.00-5.6%+8.6%$5.74B$5.00B29.375,600News CoveragePositive NewsGap DownGHGuardant Health4.2144 of 5 stars$42.60-1.3%$48.95+14.9%+113.3%$5.26B$739.02M-11.971,790Positive NewsGap DownRDNTRadNet3.9279 of 5 stars$49.72+0.6%$73.25+47.3%+3.1%$3.68B$1.83B-710.188,970Positive NewsGap DownSHCSotera Health2.4519 of 5 stars$11.66-0.9%$16.00+37.2%-7.0%$3.31B$1.10B46.643,000News CoveragePositive NewsBTSGBrightSpring Health Services3.2005 of 5 stars$18.09+0.3%$21.67+19.8%+70.3%$3.17B$11.27B-69.5835,000Positive NewsCONConcentra Group Holdings ParentN/A$21.71+1.3%$28.50+31.3%N/A$2.76B$1.90B14.3811,000Positive NewsPRVAPrivia Health Group2.8468 of 5 stars$22.45-0.6%$26.67+18.8%+21.9%$2.71B$1.74B224.52810Insider TradeNews CoveragePositive NewsGap DownLFSTLifeStance Health Group2.4355 of 5 stars$6.66-0.6%$8.63+29.5%+11.4%$2.56B$1.25B-25.626,640Analyst ForecastOptions VolumeNews CoveragePositive NewsWGSGeneDx1.8594 of 5 stars$88.57-3.9%$72.33-18.3%+747.7%$2.49B$305.45M-45.191,200Gap Down Remove Ads Related Companies and Tools Related Companies Hims & Hers Health Competitors Option Care Health Competitors Guardant Health Competitors RadNet Competitors Sotera Health Competitors BrightSpring Health Services Competitors Concentra Group Holdings Parent Competitors Privia Health Group Competitors LifeStance Health Group Competitors GeneDx Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGRY) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SGRY Stock Free SGRY Stock Alerts